Bone marrow cells regenerate infarcted myocardium - PubMed (original) (raw)
. 2001 Apr 5;410(6829):701-5.
doi: 10.1038/35070587.
J Kajstura, S Chimenti, I Jakoniuk, S M Anderson, B Li, J Pickel, R McKay, B Nadal-Ginard, D M Bodine, A Leri, P Anversa
Affiliations
- PMID: 11287958
- DOI: 10.1038/35070587
Bone marrow cells regenerate infarcted myocardium
D Orlic et al. Nature. 2001.
Abstract
Myocardial infarction leads to loss of tissue and impairment of cardiac performance. The remaining myocytes are unable to reconstitute the necrotic tissue, and the post-infarcted heart deteriorates with time. Injury to a target organ is sensed by distant stem cells, which migrate to the site of damage and undergo alternate stem cell differentiation; these events promote structural and functional repair. This high degree of stem cell plasticity prompted us to test whether dead myocardium could be restored by transplanting bone marrow cells in infarcted mice. We sorted lineage-negative (Lin-) bone marrow cells from transgenic mice expressing enhanced green fluorescent protein by fluorescence-activated cell sorting on the basis of c-kit expression. Shortly after coronary ligation, Lin- c-kitPOS cells were injected in the contracting wall bordering the infarct. Here we report that newly formed myocardium occupied 68% of the infarcted portion of the ventricle 9 days after transplanting the bone marrow cells. The developing tissue comprised proliferating myocytes and vascular structures. Our studies indicate that locally delivered bone marrow cells can generate de novo myocardium, ameliorating the outcome of coronary artery disease.
Comment in
- Cardiovascular biology. Hearts and bones.
Sussman M. Sussman M. Nature. 2001 Apr 5;410(6829):640-1. doi: 10.1038/35070687. Nature. 2001. PMID: 11287932 No abstract available. - Stem cells: lost in translation.
Chien KR. Chien KR. Nature. 2004 Apr 8;428(6983):607-8. doi: 10.1038/nature02500. Nature. 2004. PMID: 15034595 No abstract available. - No consensus on stem cells.
[No authors listed] [No authors listed] Nature. 2004 Apr 8;428(6983):587. doi: 10.1038/428587a. Nature. 2004. PMID: 15071558 No abstract available.
Similar articles
- Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.
Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, Nurzynska D, Kasahara H, Zias E, Bonafé M, Nadal-Ginard B, Torella D, Nascimbene A, Quaini F, Urbanek K, Leri A, Anversa P. Kajstura J, et al. Circ Res. 2005 Jan 7;96(1):127-37. doi: 10.1161/01.RES.0000151843.79801.60. Epub 2004 Nov 29. Circ Res. 2005. PMID: 15569828 - Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair.
Yano T, Miura T, Ikeda Y, Matsuda E, Saito K, Miki T, Kobayashi H, Nishino Y, Ohtani S, Shimamoto K. Yano T, et al. Cardiovasc Pathol. 2005 Sep-Oct;14(5):241-6. doi: 10.1016/j.carpath.2005.05.004. Cardiovasc Pathol. 2005. PMID: 16168896 - Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.
Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK. Fazel S, et al. J Clin Invest. 2006 Jul;116(7):1865-77. doi: 10.1172/JCI27019. J Clin Invest. 2006. PMID: 16823487 Free PMC article. - Bone marrow stem cells regenerate infarcted myocardium.
Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Orlic D, et al. Pediatr Transplant. 2003;7 Suppl 3:86-8. doi: 10.1034/j.1399-3046.7.s3.13.x. Pediatr Transplant. 2003. PMID: 12603699 Review. - Autologous cell transplantation for the treatment of damaged myocardium.
Penn MS, Francis GS, Ellis SG, Young JB, McCarthy PM, Topol EJ. Penn MS, et al. Prog Cardiovasc Dis. 2002 Jul-Aug;45(1):21-32. doi: 10.1053/pcad.2002.123466. Prog Cardiovasc Dis. 2002. PMID: 12138412 Review.
Cited by
- Rebuilding the myocardial microenvironment to enhance mesenchymal stem cells-mediated regeneration in ischemic heart disease.
Chu Q, Jiang X, Xiao Y. Chu Q, et al. Front Bioeng Biotechnol. 2024 Sep 20;12:1468833. doi: 10.3389/fbioe.2024.1468833. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39372432 Free PMC article. Review. - Role of mesenchymal stem cells in sepsis and their therapeutic potential in sepsis‑associated myopathy (Review).
Wang D, Xu L, Liu Y, Wang C, Qi S, Li Z, Bai X, Liao Y, Wang Y. Wang D, et al. Int J Mol Med. 2024 Nov;54(5):92. doi: 10.3892/ijmm.2024.5416. Epub 2024 Sep 2. Int J Mol Med. 2024. PMID: 39219272 Free PMC article. Review. - Challenges and perspectives of heart repair with pluripotent stem cell-derived cardiomyocytes.
Eschenhagen T, Weinberger F. Eschenhagen T, et al. Nat Cardiovasc Res. 2024 May;3(5):515-524. doi: 10.1038/s44161-024-00472-6. Epub 2024 May 14. Nat Cardiovasc Res. 2024. PMID: 39195938 Review. - Healing the Ischaemic Heart: A Critical Review of Stem Cell Therapies.
Tonkin D, Yee-Goh A, Katare R. Tonkin D, et al. Rev Cardiovasc Med. 2023 Apr 19;24(4):122. doi: 10.31083/j.rcm2404122. eCollection 2023 Apr. Rev Cardiovasc Med. 2023. PMID: 39076280 Free PMC article. Review. - Nano-vibration exciter: Hypoxia-inducible factor 1 signaling pathway-mediated extracellular vesicles as bioactive glass substitutes for bone regeneration.
Wang Z, Dai Q, Luo H, Han X, Feng Q, Cao X. Wang Z, et al. Bioact Mater. 2024 Jun 25;40:460-473. doi: 10.1016/j.bioactmat.2024.06.023. eCollection 2024 Oct. Bioact Mater. 2024. PMID: 39036347 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical